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Rheumatoid arthritis is a chronic inflammatory disease with a high prevalence and substantial socioeconomic burden.
Despite intense research efforts, its aetiology and pathogenesis remain poorly understood. To identify novel genes
and/or cellular pathways involved in the pathogenesis of the disease, we utilized a well-recognized tumour necrosis
factor-driven animal model of this disease and performed high-throughput expression profiling with subtractive cDNA
libraries and oligonucleotide microarray hybridizations, coupled with independent statistical analysis. This twin
approach was validated by a number of different methods in other animal models of arthritis as well as in human
patient samples, thus creating a unique list of disease modifiers of potential therapeutic value. Importantly, and
through the integration of genetic linkage analysis and Gene Ontology–assisted functional discovery, we identified the
gelsolin-driven synovial fibroblast cytoskeletal rearrangements as a novel pathophysiological determinant of the
disease.
Citation: Aidinis V, Carninci P, Armaka M, Witke W, Harokopos V, et al (2005) Cytoskeletal rearrangements in synovial fibroblasts as a novel pathophysiological determinant of
modeled rheumatoid arthritis. PLoS Genet 1(4): e48.
Introduction
Rheumatoid arthritis (RA) is a chronic destructive arthrop-
athy with a prevalence of 1–3% and substantial personal,
social, and economic costs. It is characterized by prolonged
inﬂammation of the joints, eventually leading to destruction
of the cartilage and bone. Inﬂammation is initially localized
in the synovial lining, a monolayer of synovial cells that lines
diarthroidal joints. In RA, the synovial lining becomes
markedly thickened due to synovial cell proliferation and
inﬁltration by inﬂammatory cells. This proliferative mass, the
pannus, invades and destroys articular cartilage and bone,
leading to irreversible destruction of joint structure and
function [1]. Current therapies of RA rely mainly on
symptomatic treatment with nonsteroidal antiinﬂammatory
drugs and/or with disease-modifying antirheumatic drugs.
However, even the best available treatments (such as targeting
tumour necrosis factor [TNF] and TNF signalling) do not cure
the disease and do not even sufﬁciently retard progression in
the majority of the patients, while they often exhibit adverse
side effects [2].
Despite intense efforts, the aetiology and pathogenesis of
RA remain poorly understood. Traditional research para-
digms for RA have implicated a variety of mechanisms that
contribute to the initiation and perpetuation of synovial
inﬂammation, including autoantibodies and immune com-
plexes, T cell-mediated antigen-speciﬁc responses, persis-
tence of cytokine networks and other proinﬂammatory
molecules, genetic bias and sex predisposition, and tumour-
like behaviour of the arthritic synovium [3]. Animal models of
RA share many clinical features with the human disease and
hence constitute valuable tools in deciphering the pathogenic
mechanisms that govern disease activation and perpetuation
[4]. Among them, the TNF-transgenic (TNF-Tg) mouse [5] has
been instrumental in demonstrating the role of TNF in the
development of the disease and foreshadowed the introduc-
tion and success of anti-TNF therapies that transformed the
effective management of the disease [6]. In this model,
chronic overexpression of human TNF results in a chronic,
erosive, symmetric polyarthritis, with 100% phenotypic
penetrance, timed disease onset, and progressive histological
symptoms that closely resemble human RA [5–7].
To gain further insights into the pathophysiology of the
disease and to discover genes and/or pathways involved in its
pathogenesis, we have utilised the TNF-Tg animal model of
RA for large-scale expression proﬁling with both subtractive
libraries and oligonucleotide microarray hybridizations.
Differential expression was validated by a number of
methods, in both mouse and human patient samples, thus
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therapeutic targets. Moreover, in an attempt to discover
deregulated cellular functions based on functional annota-
tions of deregulated genes, we identiﬁed the gelsolin-driven
synovial ﬁbroblast cytoskeleton rearrangement as a patho-
physiological determinant of the disease.
Results
To discover genes and cellular pathways that participate in
the pathogenesis of RA on a large scale, we used a twin high-
throughput approach, comprising two entirely different
methodologies governed by different constraints and ana-
lyzed by different statistics. Total RNA samples were
extracted from whole-joint (WJ) and synovial ﬁbroblast (SF)
ex vivo cultures isolated from 6-wk-old mice with RA (Tg197,
hTNF
þ/ ; disease severity index 3; [5]) and their normal (wild-
type [WT]) littermates. Each sample (out of four: RA SF, WT
SF, RA WJ, and WT WJ) consisted of equimolar amounts of
RNA pooled from four (two male and two female) mice (16
mice altogether), to some extent equalizing biological
diversity. Biological replicates (different extractions from
independent mice, employing the same extraction protocols
and pooling strategy) were used for both the creation of
subtractive cDNA libraries and the hybridization of oligonu-
cleotide microarrays.
Subtractive cDNA Libraries and Large-Scale Sequencing
Four different full-length cDNA libraries (RA SF, WT SF,
RA WJ, and WT WJ) were normalized and subtracted to each
other, as outlined in Figure S1A. Due to experimental design,
the resulting subtracted libraries (L0, L1, L2, and L7)
contained cDNAs from the tester cDNA library only and
therefore constituted libraries of up-regulated genes in the
corresponding tester library (or of down-regulated genes in
the driver library). From the subtractive libraries, 27,511
cDNAs/clones were sequenced and clustered to 9,176 clusters/
genes, as summarized in Figure S1B. Each gene was then
annotated through BLAST homology searches at Unigene,
FANTOM, and SWISSPROT databases.
In summary, among the 9,176 genes found, 7,977 corre-
sponded to known genes, while 1,199 had sequences not
reported previously. Each gene was represented by a different
number of clones in almost all libraries, directly proportional
to subtraction efﬁciency and transcript abundance. The
relative distribution of each gene in each library is the true
measure of differential expression, which can be obscured by
sampling errors arising by chance when the clones are
selected. Therefore, in order to identify the truly differ-
entially expressed genes, a likelihood value (R) was assigned to
each gene from pairwise comparisons of the relative libraries
(SF/L0L1 and WJ/L2L7). The statistical signiﬁcant thresholds
were then calculated (Figure S2), and two signiﬁcance levels
were selected (summarized in Table 1): a very high one
(99.99%; p   0.0001) to report the results independently, and
a lower one (99%; p   0.01) for comparison with the
corresponding results from the DNA microarray hybrid-
izations. Known (by a Unigene cluster ID) differentially
expressed genes at 99.99% signiﬁcance level are presented
in Table S1.
Oligonucleotide Microarray Hybridizations
Fluorescently labeled cRNA probes made from similar
(biological replicates, see above) samples of total RNA (RA SF,
WT SF, RA WJ, and WT WJ) were utilized to hybridize in
duplicate the Affymetrix Mu11K oligonucleotide DNA
chipset (eight chipsets, 16 chips total). Furthermore, similar
samples (equimolar amounts of RNA pooled from four—two
male and two female—6-wk-old arthritic mice; severity index
3) of total RNA (from SF and WJ) from another animal model
of arthritis (spontaneous, knock-in, TNF
DAREþ/-) [8] were used
for additional chip hybridizations (four chipsets, eight chips
total). The MIAME-compliant [9] microarray data (see the
ArrayExpress database [10], accession number E-MEXP-255)
were normalized and analyzed as outlined in Figure S3 and
described in detail in Materials and Methods and Figure S4.
Differentially expressed genes (DEGs) were selected, utilizing
a sample-speciﬁc fold-change model (FCM) [11] at different
signiﬁcance levels (90%, p   0.1; 95%, p   0.05), where
selected DEGs have always an observed fold-change higher
than the expected fold-change. The results for both animal
models are summarized in Table 2. Sample-speciﬁc DEGs
common to both animal models (signiﬁcance: 95%, p   0.05)
are presented in Table S2.
Cross-Platform Comparison and Validation
Both differential expression analysis methods presented
above produced lists of deregulated genes of high statistical
signiﬁcance. To validate the results independently and to
avoid performing numerous RT-PCRs, differential expression
results by both platforms of analysis were compared to each
other for the same animal model (Tg197, hTNF
þ/-), sample
type (WJ, SF), and direction of deregulated expression (up or
down). The comparison, at signiﬁcance levels 99% for the
libraries and 90% for the microarrays (selected based on
similar output gene numbers), was performed through the
NetAffx database (http://www.affymetrix.com). Although few
examples of expression proﬁling cross-platform overlaps have
been reported [12,13], in this study 46 genes (15 for SF, 31 for
WJ) were commonly predicted as up- or down-regulated by
both methods (combined p-value of 0.001) (Table 3).
To verify the validity of the twin high-throughput approach
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Synopsis
Rheumatoid arthritis (RA) is a chronic destructive disease that affects
1–3% of the general population, exacting substantial personal,
social, and economic costs. Current treatments alleviate the
symptoms and offer immediate relief for many patients but do
not cure the disease. While the cause of the disease remains poorly
understood, the completion of the Human Genome Project and the
emergence of functional genomics and high-throughput technolo-
gies offer intriguing new possibilities. For example, expression
profiling creates a molecular fingerprint of the disease status by
quantifying the expression levels of thousand of genes simulta-
neously. Similarly, reverse genetics (the genetic modification of a
particular gene in search of its function) allow for the creation of
animal models of disease. To discover novel genes and/or cellular
pathways involved in the development of the disease, the authors
used two methods in an animal model of RA for large-scale
expression profiling. They identified a large number of genes and
molecular processes that are deregulated in the disease. Using this
information, the authors described pathophysiologic determinants
of RA and created a unique list of disease modifiers of potential
therapeutic value.and to prove that the reported gene list is self-validated, a
number of the predicted deregulated genes were conﬁrmed
with different methods. Expression proﬁling in the knock-in
disease model (TNF
DAREþ/-) conﬁrmed 40 of the genes (Table
3). Automated literature text mining (Biolab Experiment
Assistant, BIOVISTA, Greece) identiﬁed 20 of the genes
previously associated with RA (Figure S5; summarized in
Table 3). In addition, 11 representative genes (SF: Gsn, Aqp1,
mglap, cdc42 hom, and Hp; WJ: Marco, Hp, CD14, Mb, Bsg, Ptgis)
were further conﬁrmed by semi-quantitative (SQ) RT-PCR
(Figure S6A–S6C; summarized in Table 3). All SQ-RT-PCRs
were performed in the linear range of the reaction (at three
different concentrations normalized against housekeeping
genes) in biological replicates (different extractions from
independent mice, employing the same extraction protocols
and pooling strategy) of the samples used for both the
subtractive libraries and the microarray hybridizations.
Representative genes were selected on the basis of (1)
different sample source (six from WJs and ﬁve from SFs), (2)
different direction and degree of deregulated expression (six
up-regulated and ﬁve down-regulated), and (3) biological
interest and potential follow-up. Moreover, two of them (SF:
Gsn, Aqp1) were also conﬁrmed by real-time RT-PCR (Figure
S6D; summarized in Table 3).
In an attempt to combine gene expression analysis with
genetic linkage analysis, all differentially expressed genes
were mapped to the chromosomes together with the known
quantitative trait loci (QTL, chromosomal regions/genes
segregating with a quantitative trait) for an induced animal
model of arthritis, collagen-induced arthritis (CIA) [14]. As
graphically represented in Figure 1 (and summarized in Ta-
ble 3), eight genes mapped to CIA QTL (WJ: Ctss, Pitpnm, Ncf1,
Psmb8, and Siat8e, SF: Rab14, Aqp1, and Gsn).
The expression level of seven of the genes found
deregulated in the arthritic mice and conﬁrmed by RT-PCR
in mouse samples, was also examined in human patients’ RNA
samples with real-time RT-PCR analysis. Due to the lack of
normal (WT) human synovium samples, we compared the
expression of 19 RA samples with eight osteoarthritis samples
as controls, a consensus strategy for differential expression
analysis in arthritis [15,16]. As shown in Figure 2 and
summarized in Table 3, the deregulated expression of six
(out of seven assayed) of the genes was conﬁrmed in humans
as well, including four with high statistical signiﬁcance (Gsn,
Aqp1, Bsg, and Mb), thus extending the validity and utility of
the mouse model-generated deregulated gene list to the
human disease.
Arthritic Synovial Fibroblasts Have a Rearranged
Cytoskeleton
The twin high-throughput expression proﬁling approach
described above yielded a large number of disease-implicated,
deregulated genes of high statistical signiﬁcance. Further-
more, to (1) prove the validity and extend the utility of the
expression data analysis even further, (2) infer deregulated
biological functions from the gene expression data, and (3)
deﬁne functional criteria for further gene selection, the
selected genes were annotated in the form of the Gene
Ontology (GO) [17] term ‘‘biological process.’’ GO term
frequencies in the selected gene lists were then calculated,
and their statistical signiﬁcance was estimated. As shown in
Table S3, predicted deregulated functions in SFs include, as
expected, collagen catabolism, complement activation, and
immune and stress responses. Interestingly, ﬁve out of 26
signiﬁcantly (p , 0.01) deregulated GO functions concerned
(directly or indirectly) the actin cytoskeleton, suggesting that
arthritic SFs have a rearranged actin cytoskeleton. In order to
conﬁrm the prediction, F-actin was visualized in vitro on
arthritic as well as WT SFs (both primary and immortalized)
in mice. As is evident from Figure 3A, arthritic SFs exhibit
pronounced stress ﬁbers, thus validating the in silico,
expression-based hypothesis.
Stress ﬁbers within ﬁbroblasts allow them to exert tension
on the extracellular matrix (ECM) surrounding them—an
essential process in wound healing. It is well understood that
differences in the actin cytoskeleton reﬂect altered ECM
attachment properties and/or vice versa. Indeed, arthritic SFs
were shown to adhere to different proteins of the ECM
(ﬁbronectin, vitronectin, laminin, and collagen) with in-
creased afﬁnity in vitro (Figure 3B).
Attachment to the ECM (and associated cytoskeletal
changes), mediated mainly through engagement and cluster-
ing of transmembrane integrin molecules, largely deﬁne cell
shape and morphology, as well as their behavior and fate.
Increased adhesion to the ECM is expected to lead to a more
elongated shape. In order to conﬁrm the increased adhesion
of the arthritic ﬁbroblasts in vivo, we examined ankle joints
from arthritic or WT littermate mice on an ultrastructural
level with transmission electron microscopy (Figure 3C). In
WT mice, SFs contained prominent nuclei, abundant rough
endoplasmic reticulum (r-ER), and mitochondria of different
shapes and sizes. In contrast, remarkable modiﬁcation of the
Table 1. Summary Results of Subtractive Libraries and Micro-
array Hybridizations
Sample Total Genes Unigene FANTOM Novel
99% 99.99% 99% 99.99% 99% 99.99% 99% 99.99%
SF 288 23 264
a 20
b 14 1 10 2
WJ 653 95 552
a 77
b 30 3 71 15
Summary results of subtractive libraries. ‘‘Total genes’’ column includes number of statistically significant
deregulated clusters/genes; ‘‘Unigene’’ column, number of total genes with a Unigene cluster ID; ‘‘FANTOM’’
column number of total genes with a FANTOM accession number. Percentages indicate statistical specificities.
aGenes used for the cross-platform comparison presented in Table 3.
bGenes presented in Table S1.
DOI: 10.1371/journal.pgen.0010048.t001
Table 2. Summary Results of Oligonucleotide Microarray
Hybridizations
Sample Tg197 TNF
DARE Common
90% 95% 90% 95% 90% 95%
SF 277
a 98 752 363 95 38
b
WJ 830
a 498 1226 636 413 227
b
Summary results of oligonucleotide microarray hybridizations. Numbers correspond to Affymetrix probesets.
Percentages indicate statistical specificities.
aGenes used for the cross-platform comparison presented in Table 3.
bProbesets corresponding to the genes presented in Table S2.
DOI: 10.1371/journal.pgen.0010048.t002
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Expression Profiling of Modeled ArthritisSFs was noticed in the joints of the arthritic mice, where most
randomly ﬂattened cells had an elongated shape character-
ized by dilation of the r-ER and by swollen mitochondria with
distorted cristae.
Therefore, it seems that one of the pathogenic mechanisms
in RA is the promotion of actin polymerization and
rearrangement of the actin cytoskeleton. Gelsolin (Gsn) is a
gene that maps in one of the CIA QTLs (see Figure 1), and its
expression was found down-regulated in arthritic SFs by both
subtractive libraries and microarray hybridizations (see Table
3). Its deregulated expression was conﬁrmed by real-time RT-
PCR in both mouse (see Figure S6D) and human samples
(Figure 2), as well as by Western blot in immortalized SFs (see
Figure S6E). The gene encodes an actin-binding protein with
ﬁlament-severing properties [18], and Gsn
 /  ﬁbroblasts have
excessive actin stress ﬁbers [18], very similar to the ones
observed in arthritic SFs (see Figure 3A). In order to prove
the involvement of cytoskeletal organization in the patho-
genesis of RA and to highlight the role of gelsolin in it, the
arthritic mice (Tg197, hTNF
þ/ ) were mated with the gsn
knockout mice (gsn
 / ) [18]. Knocking out gsn expression from
SFs should promote RA pathogenesis by inhibiting the
severing activity of gelsolin. Indeed, and as shown in Figure
4, abolishing gsn expression resulted in hyperplasia of the
synovial membrane and exacerbation of the disease.
Discussion
Twin Expression Profiling, Statistical Analysis, and
Validation
Expression proﬁling, the relative quantiﬁcation of the
expression levels of thousands of genes simultaneously, is one
of the most promising approaches for understanding
mechanisms of differentiation, development, and disease.
However, the small number of samples usually employed
Figure 1. Chromosomal Localization of Identified Deregulated Genes in the RA Animal Model, Together with the QTL for CIA
Red and green arrowheads indicate up- and down-regulated genes, respectively. Black and blue lettering refers to deregulated genes in WJs and SFs,
respectively.
DOI: 10.1371/journal.pgen.0010048.g001
Figure 2. Confirmation of Deregulated Expression in Human Patient
Samples
Quantitative RT-PCR for the indicated genes for 19 RA and eight
osteoarthritis (OA) samples. Values were normalized to the expression of
B2m and were expressed as expression index. Similar results were
obtained upon normalization to L32. Nonparametric Mann-Whitney
statistical tests were used to derive p-values.
DOI: 10.1371/journal.pgen.0010048.g002
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Expression Profiling of Modeled ArthritisFigure 3. Mouse Arthritic SFs have a Rearranged Cytoskeleton and Increased ECM Adhesion
(A) Immunofluoresence of arthritic (RA) or normal (WT) primary and immortalized synovial fibroblasts (pSFs and iSFs respectively) for F-actin.
(B) Adhesion assays of arthritic (RA) or normal (WT) primary and immortalized SFs on purified ECM components as described in Materials and Methods.
Error bars indicate standard deviation of triplicate samples from their mean value.
(C) Transmission electron microscopy (TEM, magnification 5,0003) of SFs from ankle joints isolated from WT and arthritic mice. Arrowheads indicate
dilation r-ER, while arrows point to swollen mitochondria with distorted cristae. N, nuclei.
DOI: 10.1371/journal.pgen.0010048.g003
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Expression Profiling of Modeled Arthritissubstantially limits statistical analysis and precludes applica-
tion of complex multivariate methods, which would be more
appropriate for polygenic diseases such as RA. As a
consequence, results should be conﬁrmed by an independent
biological method, which largely diminishes the high-
throughput nature and discovery rate of any given approach.
To overcome these problems and increase the discovery
rate, we used a twin high-throughput approach composed of
subtractive cDNA libraries and oligonucleotide DNA micro-
array hybridizations. Both methodologies are governed by
different constraints: random chance for the libraries’
robotic clone selection and chip design for the microarrays.
Consequently, both methodologies are completely uncorre-
lated towards the propagation of error. Therefore, the
intersection of their statistically signiﬁcant deregulated gene
lists is expected to have a very low false discovery rate. To
illustrate this and to exhibit the validity of the twin high-
throughput approach, a number of representative genes from
the commonly selected list was conﬁrmed by a number of
different methods, such as automated literature search and
SQ and quantitative RT-PCR in both mouse and human
samples. Therefore, we have shown that coupling two differ-
ent high-throughput approaches largely decreases the need
for independent conﬁrmation and consequently increases the
number of likely deregulated genes.
All differentially expressed genes were mapped to the
chromosomes, together with the known QTL for an animal
model of arthritis, CIA [14]. Eight deregulated genes mapped
to CIA QTL (WJ: Ctss, Pitpnm, Ncf1, Psmb8, and Siat8e; SF:
Rab14, Aqp1, and Gsn; see Figure 1), suggesting that these
genes may have a dominant inﬂuence in arthritic processes,
irrespective of the inciting stimulus (autoimmune or inﬂam-
matory). To that end, it was recently reported that a naturally
occurring polymorphism of Ncf1 (an NADPH oxidase subunit;
QTL Cia 14) regulates arthritis severity [19] and is currently
being commercially exploited in a drug discovery pro-
gramme. Similarly, knocking out Aqp1 (which encodes a
water channel protein; QTL Cia 6) expression revealed its
fundamental role in cell migration—central to wound healing
and tumour spread [20]. Interestingly, several of the genes
cluster together in adjacent regions of the chromosomes (4, 7,
10, 11 and 13). These loci could deﬁne new QTL or imply
common regulatory control at the chromatin level.
Actin Cytoskeleton and RA Pathogenesis
For polygenic diseases such as RA, knowledge about
concerted gene functions or cellular processes might provide
valuable clues and help to prioritize targets. In this context,
we searched for deregulated processes rather than genes,
based on functional annotations of deregulated genes, as
these are formalized through the controlled vocabulary of the
Gene Ontology Consortium [17]. GO term frequencies were
calculated in the selected gene list and their statistical
signiﬁcance was estimated. The resulting list (Table S3)
includes a number of expected functions that encompass
accumulated knowledge about the pathogenesis of the
disease, such as collagen catabolism, complement activation,
and immune and stress responses. More importantly, ﬁve out
of 26 predicted deregulated GO functions concerned
(directly or indirectly) the actin cytoskeleton, thus forming
a valid hypothesis to be explored. Accordingly, F-actin stress
ﬁbers were visualized in vitro, in arthritic and WT SFs, both
primary and immortalized. As is evident in Figure 3A, there
was a striking difference, with the arthritic SFs exhibiting
pronounced stress ﬁbers. Notably, stress ﬁbers appear in
differentiated ﬁbroblasts called myoﬁbroblasts, specialized
contractile ﬁbroblasts with an important role in establishing
tension during wound healing and pathological contracture
[21,22]. This is the ﬁrst direct indication of the possible
presence of myoﬁbroblasts in the arthritic synovium,
although it has been previously reported that transforming
growth factor-b1 and interleukin-4 can induce a myoﬁbro-
blastic phenotype to SFs in vitro [23]. Consistent with this
notion, we observed that arthritic SFs have more pronounced
Figure 4. Knocking out Gelsolin Expression Results in Disease Exacerbation
(A) Histopathological scores. * p ¼ 0.025 n ¼ 8–11.
(B) Representative histopathological analysis (stained with haematoxylin-eosin) of arthritic joints. Shown images were assembled from multiple
overlapping sections. Arrows indicate the synovial membrane.
DOI: 10.1371/journal.pgen.0010048.g004
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Expression Profiling of Modeled Arthritisfocal adhesion kinase-positive islands (unpublished data), a
prominent feature of myoﬁbroblasts [22]. The actin cytoske-
leton interacts bidirectionally with the ECM through recep-
tors (mainly integrins) that possess extracellular binding sites
for laminin, collagen, ﬁbronectin, and other ECM compo-
nents. The formation of intimate, extensive adhesive contacts
between cells and ECM results from cooperation between
adhesive systems and the actin cytoskeleton and the gen-
eration of force across regions of the cell [24]. In this context,
myoﬁbroblasts are thought to exert increased tension to the
substratum through their increased adhesive capacity, which
results in a more ﬂattened, elongated cell shape [22].
Accordingly, we have observed that arthritic SFs adhere to
various ECM components with increased afﬁnity in vitro (see
Figure 3B), resulting in a more elongated shape in vivo (see
Figure 3C), further corroborating the possible existence of
myoﬁbroblasts in the arthritic synovium. In accord with this
result, the possible presence of myoﬁbroblasts in the human
arthritic synovium was recently implied, by immunohisto-
chemical analysis [25].
While the existence of myoﬁbroblasts and their role in the
pathogenesis of RA remain to be further explored, the fact
remains that the reorganization of the actin cytoskeleton and
the associated deregulation of ECM adhesion seem to be an
intrinsic property of arthritic SFs. To this end, it was recently
reported that the prevalence of speciﬁc autoantibodies
against cytoskeletal antigens is elevated in patients with RA
[26]. Autoantibodies serve as important serological markers in
the diagnosis of various autoimmune and connective tissue
diseases, including RA [27,28]. A large number of RA-speciﬁc
autoantibodies of high diagnostic value are directed against
components of the cytoskeleton: anti-vimentin, anti-keratin,
and anti-ﬁlaggrin [28]. Filaggrin is a keratin cross-linker, an
intermediate ﬁlament-aggregating protein, that can affect
other cytoskeletal elements, including actin microﬁlaments,
by a mechanism similar to actin ﬁlament severing by gelsolin
[29]. Most of the above-mentioned autoantibodies recognize
the citrullinated form of cytoskeletal proteins [30]. Since
citrullination of proteins is not speciﬁc for RA, our results
may provide the molecular basis, by a yet unknown mecha-
nism, for the presence of anti-cytoskeleton antibodies in RA.
Recent experiments have shown that the cytoskeleton plays
a critical role in the regulation of various cellular processes
linked to cell transformation and tumorigenesis, such as
contact inhibition and anchorage-independent cell growth
[31]. Accumulated evidence suggesting that arthritic SFs also
exhibit characteristic of transformed cells led to the working
hypothesis that the arthritic synovium is a locally invasive
tumour [32]. The rearranged cytoskeleton in arthritic SFs
therefore reinforces the concept of a transformed-like
character of the SF and opens up new directions in the
pharmacological treatment of RA.
Gelsolin is an actin-binding protein [33] that has been
implicated, among others, in the transduction of signals into
dynamic rearrangements of the cytoskeletal architecture. In
the presence of calcium, gelsolin severs preexisting actin
ﬁlaments and caps them, thereby preventing monomer
addition to their fast-growing ends. The barbed end cap is
highly stable, even in the absence of calcium, unless displaced
by interactions with regulatory phospholipids such as
phosphatidylinositol-4,5-bisphosphate. In the presence of a
large pool of proﬁlin (another actin-binding protein), or
under depolymerizing conditions, these gelsolin-capped ends
allow the disassembly of populations of actin ﬁlaments by
subunit loss from the pointed ends [34]. Gsn
 /  ﬁbroblasts
were found to have excessive stress ﬁbers in vitro [18], similar
to the ones observed in arthritic SFs, where gelsolin was
found to be down-regulated by a variety of methods.
Knocking out Gsn expression from the arthritic mice resulted
in exacerbation of the disease (Figure 4), therefore proving
the participation of the actin cytoskeleton rearrangement in
the pathophysiology of the disease. Extending the similarities
of the arthritic synovium with tumours, gelsolin was found to
be one of the most strikingly down-regulated markers upon
malignant transformation of ﬁbroblasts by Ras [35], while
overexpression of a gelsolin mutant was shown to suppress
Ras-induced transformation [36]. Its expression was unde-
tectable or reduced in a majority of human gastric, bladder,
lung, colon, and breast tumours [37–39].
Conclusion
We have shown that the combination of sequencing of
subtractive cDNA libraries and microarray expression anal-
ysis is highly reliable and yields self-validated targets and,
when integrated with other functional genomics approaches
such as genetic linkage and GO-assisted functional discovery,
can provide novel insights into the pathophysiology of RA. As
an example, we have investigated one of the predicted
deregulated cellular processes, cytoskeletal organization,
and one of the predicted deregulated genes involved in these
processes, gelsolin, to show that gelsolin-driven actin cytos-
keleton rearrangement is a novel pathophysiological deter-
minant of RA.
Materials and Methods
Animals. All mice were bred at the animal facilities of the
Alexander Fleming Biomedical Sciences Research Center under
speciﬁc pathogen-free conditions, in compliance with the Declara-
tion of Helsinki principles. Mice were housed at 20–22 8C, 55 6 5%
humidity, and a 12-h light-dark cycle; water was given ad libitum.
‘‘Arthritic’’ transgenic mice (Tg197, hTNF
þ/  maintained on a mixed
CBA3C57BL/6 genetic background for over 20 generations), carried
the human TNF gene where the 39 UTR was replaced by the
corresponding one from b-globin [5]. ‘‘Arthritic’’ knockin mice
(TNF
DARE/þ maintained on a 129/C57BL6 background for over 20
generations) expressed the endogenous mTNF gene, where 69 bp
encompassing the TNF ARE (AU-rich elements) at the 39 UTR have
been deleted, resulting in increased message stability and transla-
tional efﬁciency [8].
Cell isolation and culture. SFs (VCAM
þ) were isolated from 6- to 8-
wk-old mice essentially as previously described [7]. Fibroblasts were
selected by continuous culturing for at least 21 d and a minimum of
four passages. No macrophage markers could be detected by FACS
analysis. Cells were grown at 37 8C, 5% CO2 in complete DMEM
medium (Gibco-BRL, San Diego, California, United States) supple-
mented with 10% FBS and 100 U/ml of penicillin-streptomycin. The
creation and culture conditions (33 8C, 10 U/ml of murine rIFN-c)o f
conditionally immortalized SF cell lines has been described pre-
viously [7].
RNA extraction. Total RNA was extracted from subconﬂuent (70–
80%) cultured SFs (primary or conditionally immortalized) with the
RNAwiz reagent (Ambion, Austin, Texas, United States), followed by
single passage through an RNeasy column (QIAGEN, Hilden,
Germany) according to manufacturers’ instructions. Total RNA was
extracted from WJs using the guanidinium isothiocynate-acid phenol
protocol [40], followed by a single passage through an RNeasy
column. RNA integrity was assessed by electrophoresis on denaturing
1.2% agarose-formaldehyde gels. RNA quantity and quality were
calculated based on OD readings at 260/280 nm.
Generation of full-length cDNA libraries. First-strand cDNA
synthesis was performed using SUPERSCRIPT II (Life technologies/
Invitrogen) at 56 8C in the presence of trehalose and sorbitol. The cap
structure at the 59 end of mRNAs was biotinylated, and full-length
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coated beads [41]. Second-strand synthesis was primed by the single-
strand linker ligation method (SSLLM), where a double-stranded DNA
linker (with random 6-bp, dN6 or dGN5, 39 overhangs) is ligated to the
single-stranded cDNA [42]. The second strand is made by primer
extension using mixtures of long-range thermostable polymerases,
followed by restriction digestion (BamHI and XhoI) and ligation to
the k-FLCI phagemid vector [42,43]. After packaging, cDNA libraries
were ampliﬁed on solid phase, as previously described [44].
cDNA library normalization and subtraction. The procedure is
outlined in Figure S1A. Ampliﬁed phagemid k-FLCI cDNA libraries
were used to infect the Cre-expressing bacterial cell line BNN-132
and the excised plasmids were isolated [43]. Double-stranded plasmid
DNA was nicked by the site-speciﬁc (f1 origin) endonuclease GeneII
and converted to circular single-stranded form by digestion with
exonuclease III [44]. Circular, single-stranded plasmid cDNA libraries
(tester libraries) were then subjected to a single normalization-
subtraction step, with PCR-derived single strand antisense DNA
drivers produced from these libraries [44]. Normalization refers to
low CoT (reassociation rate) hybridization (CoT ¼ 2) with drivers
produced from the ‘‘self’’ library, and it aims to decrease the
representation of highly expressed mRNAs. Subtraction refers to
high CoT hybridization (CoT¼100;200) with drivers produced from
different libraries, and it aims to remove mRNAs common in both
populations. Hybridized double-stranded cDNAs were removed with
two passes through a hydroxyapatite column. Nonhybridized, single
stranded cDNAs were converted to double stranded and were
subsequently electroporated into DH10b bacterial cells, where only
tester cDNAs are able to propagate (due to the presence of a
replication origin and antibiotic resistance) [44].
High-throughput sequencing and sequence analysis. Colony pick-
ing, cDNA sequencing and sequence analysis were performed
essentially as previously described [45–47]. Sequences were ﬁltered
for primer and vector sequences [47] and masked for rodent-speciﬁc
and mammalian-wide repeats with RepeatMasker (http://www.phrap.
org). EST clustering was performed with stackPACK and d2_cluster
(word size 6, similarity cutoff 0.98, minimum sequence size 50,
window size 200) [48,49]. Homology searches with known genes were
performed with BLAST [50,51] in the Unigene (http://www.ncbi.nlm.
nih.gov/UniGene), FANTOM2 (http://fantom2.gsc.riken.go.jp) [52],
and SWISSPROT (http://www.ebi.ac.uk/ swissprot/) databases. BLAST
results were associated with GO terms (http://www.geneontology.org)
at http://source.stanford.edu/cgi-bin/sourceSearch (for Unigene), ftp://
ftp.ebi.ac.uk/pub/databases/GO/goa/ SPTR/gene_association.
goa_sptr.gz (for SWISSPROT), and http:// fantom2.gsc.riken.go.jp
(for FANTOM2). The detailed results (including clone numbers,
clusters/genes, BLAST results and E values, accession numbers, and
GO assignments) can be found in the corresponding author’s Web
site, at http://www.ﬂeming.gr/en/investigators/Aidinis/data.html. Most
of the sequencing data, have been already submitted to public
databases [46], in the context of the ongoing FANTOM (Functional
annotation of the mouse) project [52,53].
Differential gene expression statistical analysis of subtractive
libraries. The differential gene expression/abundance among the
different subtracted cDNA libraries was calculated with a single
statistical test designed especially for this purpose [54]. Essentially,
the formula is the entropy of a partitioning of genes among cDNA
libraries and is described by an R-value, which is the log likelihood
ratio statistic, that follows (2Rj) an asymptotic v
2 distribution [54].
The formula for the statistic Rj for the j
th gene is given by the
expression:
Rj ¼
X m
i¼1
vi;jlog
vi;j
Nifj
  
ð1Þ
where
fi ¼
X m
i¼1
vi;j
X m
i¼1
Ni
ð2Þ
where m is the number of cDNA libraries, Ni is the total number of
clones sequenced in the i
th library, vi,j the counts (transcript copies)
of the j
th gene in the i
th library, and fi is the frequency of gene
transcripts copies of the j
th gene in all the libraries.
The signiﬁcance of the R-statistic was established by utilizing a
resampling method that tries to establish an ‘‘optimal’’ cutoff value
using simulated library datasets based on the observed counts. The
method consists of the following steps. (1) For every gene, the
common gene transcript frequency fj is calculated with the help of
Equation 2. This number corresponds to the expected frequency of
gene transcripts under the null hypothesis of no difference in the
abundance of gene j across all libraries. (2) The parameters of the
Poisson distributions giving the sampling distribution of clone
abundance for each gene and library are calculated under the null
hypothesis. This parameter is equal to Ni 3 fj for gene j in library i,
where Ni is the total number of clones (taking into account all genes)
sequenced in library i and fj was calculated in step 1. This value is
equal to the expected absolute number of clones of the j
th gene in the
i
th library under the null hypothesis. (3) Then, for each library
compared, and each gene, a random number is generated from the
Poisson distribution of step 2. This number is a simulated count
compatible with the null hypothesis, i.e., that the gene frequency for a
particular gene is the same across all libraries. This step uses the
random number-generating function of the computer to create an
artiﬁcial dataset corresponding to the actual experiment of library
creation and analysis for each of the libraries compared under the
null hypothesis. (4) For gene j in the artiﬁcial dataset of step 3, the test
statistic R is calculated by substituting for vi,j the random number
generated in step 3, for fj the frequency calculated in step 1, and for
Ni the total number of clones sequenced. (5) The R-values calculated
in step 4 are sorted in descending order, and for a range of values for
speciﬁcity (i.e., the true negative rate), the corresponding R-value is
found. These are by deﬁnition true negatives, since they were
obtained from libraries under the null hypothesis. (6) Steps 3–5 are
repeated 1,000 times. The resulting data allowed us to construct the
histogram shown in Figure S2A. These histograms depict the
distribution of the R-value as a function of the required true
negative rate cutoff. The mean of this (empirical) distribution is used
as the R-value cutoff for the analysis of the experimental dataset. (7)
The experimental dataset R-values are computed for all the
comparative libraries using the observed clone counts. Genes with
R-values greater than the previously established cutoff are considered
to be differentially regulated between the libraries. Calculations were
performed in the Computer Algebra System Mathematica 4.2 (http://
www.wri.com) with the MathStatica add-on [55].
High density oligonucleotide array hybridization. cRNA probes
were generated from 5 lg of total RNA and hybridized to the Mu11K
(subunits A and B) chip set according to the manufacturer’s
instructions (Affymetrix, Santa Clara, California, United States) and
as previously described [7]. The chip set is designed to collectively
recognize 13,179 distinct murine transcripts, where the expression
levelofanygivengeneisinterrogatedby 40oligonucleotides,20witha
perfectmatchsequenceand20carryinga singlemismatch.Hybridized
chips were washed and stained in a Fluidics Station (Affymetrix)
following standard protocols; subsequently, ﬂuorescence intensities
werereadbyanAffymetrixscanner.AllMIAME-compliantmicroarray
data can be downloaded from the ArrayExpress database (accession
number E-MEXP-255), as well as from the corresponding author’s web
site (http://www.ﬂeming.gr/en/investigators/Aidinis/data.html).
Microarray data preprocessing and normalization. The procedure
is outlined in Figure S3. Low-level analysis of the resulting scanned
image (as background subtraction and computation of individual
probe cell intensities) was automatically performed by MicroArray
Suite 5.0 (MAS5) software (Affymetrix). Brieﬂy, the quantitative level
of expression (signal value), as well a qualitative measure of
expression (detection call), of any given gene is calculated by
proprietary Affymetrix algorithms from the combined, back-
ground-adjusted hybridization intensities of 20 perfect match and
20 single mismatch oligonucleotides (probe set). All signal values
from all chips in the experiment were scaled to reach target intensity
(TGT) of 500 or 2,500, following Affymetrix recommendations for
the individual chip sets used. Scaled values were then submitted to a
normalization step that is intended to force each chip subunit’s
signal distribution to have an identical overall shape across chips of
the same subunit. Gene expression values were reorganized into two
distinct data matrices, one for each chip set subunit (A,B), where
rows and columns represented genes and chips, respectively. The
columns of the data matrix were normalized to have the same
quantiles using BioConductor [56]. Each quantile of each column was
set to the mean of that quantile across arrays (see Figure S4A). The
rows of the two data matrices were then merged, and the columns of
the resulting data matrix were split according to the corresponding
animal model of RA (Tg197, TNF
DARE) and to the type of sample (SF
or WJ), thus obtaining a total of four distinct data matrices. Finally,
genes that were not called ‘‘present’’ (detection call) or that had a
normalized signal lower than one-ﬁfth of the TGT in at least one
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therefore performed on the remaining 8,021 probe sets.
Microarray data analysis. Comparisons of Affymetrix chips hybrid-
izations and real-time PCR have indicated that chip analyses are
accurate and reliable, and that they underestimate differences in
gene expression [57]. Nevertheless, in order to assess the system’s
performance, the reproducibility of the (technical) duplicate samples
was examined, in terms of Pearson correlation coefﬁcient of
normalized signals, as well as detection concordance (expressed as
the percentage of probe sets that were consistently detected with a
‘‘present’’ or an ‘‘absent’’ call in both chips). As can be seen in Figure
S4B, Affymetrix data were highly reproducible and reliable.
As previously reported [58,59], the signiﬁcance of fold-changes,
which are commonly used as a measure of differential expression, is
highly dependent on the expression level of the corresponding genes.
Therefore, in order to identify genes that are signiﬁcantly differ-
entially expressed, we decided not to use a ﬁxed fold-change
threshold, but instead to model intensity-dependent fold-changes
between replicated chips using a variant of a previously described
approach [60]. Brieﬂy, we ﬁrst calculated fold-changes in pairwise
comparisons of replicated chips representing the transcriptome of
the same sample type (SF or WJ) measured (under the same
experimental condition using the following deﬁnition:
FC ¼j x1   x2j=minðx1; x2Þð 3Þ
where xi was the normalized expression level of a given gene in the i
th
chip. Genes were then ranked according to the minor of their two
expression values—i.e., min(x1,x 2)—and the overall expression range
was partitioned into ten intervals, each containing an equal number
of probe sets. In each partition the median of all min(x1,x 2) values as
well as the 90
th and the 95
th percentile fold-change were determined,
thus obtaining ten distinct modeling points for each sample type (SF
or WJ) and for each of the two signiﬁcance levels (90% or 95%). Based
on the observation that measurement variability of high-density
oligonucleotide microarrays depends on signal intensity following a
power law [11], a continuous FCM was derived from the ten modeling
points using a least squares linear ﬁt in log-log plots. The following
modeling parameters have been obtained for the two FCMs (see
Figure S4C): a slope of  0.327 and an intercept of 2.356 for the SF
FCM, and a slope of 0.346 and an intercept of 2.678 for the WJ FCM.
This means that WJs are, as expected, intrinsically more variable than
SFs. Using slopes (a90% or a95%) and intercepts (b90% or b95%) of
the resulting regression curves, we could obtain for each given sample
type (SF or WJ) and for any given minimum expression level both a
90% and a 95% signiﬁcance threshold:
FC90% ¼ minðx1; x2Þa90% 3eb90% ð4Þ
FC95% ¼ minðx1; x2Þa95% 3eb95% ð5Þ
For each of the four data matrices (i.e., Tg197/SF, TNF
DARE/SF,
Tg197/WJ, and TNF
DARE/WJ), an observed average fold-change
between experimental conditions (diseased or normal) was calculated
for each gene in the following way:
FCobs ¼j l1; l2j=minðl1;l2Þð 6Þ
where li is the average expression level of a given gene in the i
th
experimental condition. If no replicates were available, the single
expression value of the given gene was used instead of the average.
For each gene, this observed fold-change was then compared to the
fold-change that was expected at a 90% (or 95%) signiﬁcance level
using the corresponding ‘‘sample type’’-speciﬁc FCM, given the
observed values of li of that gene:
FC90% ¼ minðl1; l2Þ
a90% 3eb90% ð7Þ
FC95% ¼ minðl1; l2Þ
a95% 3eb95% ð8Þ
Finally, genes with FCobs . FC90% (or . FC95%) were selected as
differentially expressed at a signiﬁcance level of 90% (or 95%,
respectively).
Visualization of QTL and gene-expression data. This was
p e r f o r m e dw i t hE x p r e s s i o nv i e w[ 6 1 ]a th t t p : / / e n s e m b l . p z r .
uni-rostock.de/Mus_musculus/expressionview. QTL data were de-
rived from Serrano-Fernandez et al. [62].
Functional clustering and determination of statistical signiﬁcance.
Biological annotation, in the form of GO ‘‘Biological process’’ term
[17],foreachofthegenes(probesets)inTable3,wasobtainedfromthe
NetAffx portal (http://www.affymetrix.com). We then calculated the
observed GO term frequencies, as means to discover deregulated
functions (Table S3). The statistical signiﬁcance of GO term frequen-
cies was determined essentially as has been previously described [63].
Brieﬂy,the hypergeometric distribution was used to obtain the chance
probabilityofobservingagivennumberofgenesannotatedinNetAffx
with a particular GO term and then calculating appropriate p-values.
More speciﬁcally, the probability of observing at least k probe sets
annotatedwithaparticularGOtermwithinalistofselectedprobesets
of size n was calculated [63] as:
P ¼ 1  
X k 1
i¼0
f
i
   g f
n 1
  
g
n
   ð9Þ
where f was the total number of genes within a functional category,
and g was the total big (number of probe sets on the chip set (13,179).
Adhesion assays. These assays were performed on Cytometrix
adhesion strips (Chemicon, Temecula, California, United States)
coated with human ﬁbronectin, vitronectin, laminin, and collagen I,
according to the manufacturer’s instructions. Brieﬂy, cells (in
triplicates) were allowed to adhere to the above-mentioned sub-
strates, and unbound cells were removed with sequential washes with
PBS containing Ca
þþ and Mg
þþ. Adhered cells were then stained with
crystal violet, solubilized, and their absorbance determined at 570 nm.
Immunoﬂuorescence. Cells were ﬁxed using 4% paraformaldehyde
in PBS and stained by standard methods. For visualizing F-actin cells
were stained with Alexa594-phalloidin (Molecular Probes, Eugene,
Oregon, United States). P-tyrosine was detected using the 4G10
antibody (Upstate Biotechnology, Waltham, Massachusetts, United
States), focal adhesion kinase was detected using a monoclonal
antibody (clone 77, BD Transduction Laboratories, Lexington,
Kentucky, United States). Antibodies against gelsolin were raised by
immunizing rabbits with recombinant mouse gelsolin; immune serum
was used at 1:500 dilution. For Western blot analysis, 10 lg of total
cell protein was separated by SDS-PAGE, transferred to Immobilon-P
membrane, probed for gelsolin, and re-probed for actin as an
internal loading control.
RT-PCR. Total RNA was extracted from SF and WJ tissue using
TRIzol reagent (Life Technologies, Rockville, Maryland, United
States) in accordance with the manufacturer’s instructions. RNA
yield and purity were determined spectrophotometrically at 260/280
nm. First-strand cDNA synthesis was performed using the MMLV
reverse transcriptase and oligo-dT15 (Promega, Madison, Wisconsin,
United States).
SQ PCR was performed by 20–25 cycles of denaturation at 95 8C
for 30 s, annealing at 57–62 8C (depending on the Tm of each
individual set of primers) for 30 s, and extension at 72 8C for 1 min, in
a ﬁnal volume of 20 ll. The products were separated by electro-
phoresis on 1.5% agarose gel and stained with ethidium bromide.
Product intensity was quantiﬁed with GelWorks 1D Advanced (v. 4.01)
and normalized to the intensity of B2m and/or L32. The primers were
selected to span two exons, while the two control primers were
chosen from the Primer Bank database (http://pga.mgh.harvard.edu/
primerbank/). Primer sequences (listed in the 59 to 39 direction, and
designated as s, sense, and as, antisense) and product sizes (in bp)
were as follows: Aqp1 (s, TCACCCGCAACTTCTCAAAC; as, AGCTCT
GAGACCAGGAAACA, 400), Bsg (s, ATGAGAAGAGGCGGAAGCCA;
as, CCACTCCACAGGGCTGTAGT, 426), Cd14 (s, CAATCCT
GAATTGGGCGAGA; as, CGAGTGGGATTCAGAGTCCA, 400),
Cdc42 (s, AAGTGGCCCAGATCCTGGAA; as, AGCACTG
CACTTTTGGGGTT, 380), Gsn (s, TGCAGGAAGACCTGGCTACT;
as, ATGGCTTGGTCCTTACTCAG, 300), Hp (s, GAAGCAATGGGT
GAACACAG; as, GGGGTGGAGAACGACCTTCT, 331), Marco (s,
CACAGGAATTCAAGGACAGA; as, ATTGTCCAGCCAGATGTTCC,
397), Mglap (s, CAGTCCCTTCATCAACAGGA; as, CTGCAGGAGA
TATAAAACGA, 274), Mb (s, TCACACGCCACCAAGCACAA; as,
TGGGCTCCAGGGTAACACTG, 354), Ptgis (s, TCACAGATGACCA
CACTCCC; as, GCAGTAGGACGACAAATTGT, 403), B2M (s,
TTCTGGTGCTTGTCTCACTGA; as, CAGTATGTTCGGCTTCC
CATTC, 104), and L32 (s, TTAAGCGAAACTGGCGGAAAC; as,
TTGTTGCTCCCATAACCGATG, 100).
Quantitative real-time PCR was performed using the iCycler iQ
Real-Time detection system and the IQ SYBR Green Supermix (Bio-
Rad Laboratories, Hercules, California, United States), according to
the manufacturer’s instructions, for one cycle of 94 8C for 4 min, and
40 cycles of denaturation at 95 8C for 50 s and annealing at 57–62 8C
for 50 s. Primers were chosen from exons separated by large introns,
and the PCR quality and speciﬁcity was veriﬁed by melting curve
analysis and gel electrophoresis. Values were normalized to B2m and/
or L32 (using the same primers as for the SQ PCR). Mouse (m) and
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(listed in the 59 to 39 direction, and designated as s, sense, and as,
antisense): mAqp 1 (s, TCACCCGCAACTTCTCAAAC; as,
TCATGCGGTCTGTGAAGTCG, 123), mGsn (s, TGCAGGAA
GACCTGGCTACT; as, TCGATGTACCGCTTAGCAGA, 130), hAqp 1
(s, CTCCCTGACTGGGAACTCG; as, GGGCTACAGAGAGGCCGAT,
182), hBsg (s, TTCCTGGGCATCGTGGCTGA; as,
GCGGACGTTCTTGCCTTTGT, 159), hCd14 (s,
CGGCGGTCTCAACCTAGAG; as, GCCTACCAGTAGCTGAGCAG,
142), hCdc42 (s, AATTGATCTCAGAGATGACC; as,
TTTAGGCCTTTCTGTGTAAG, 150), hGsn (s, GGTGTGGCATCAG
GATTCAAG; as, TTTCATACCGATTGCTGTTGGA,199), hMarco (s,
TGGGACGAGATGGAGCAAC; as, CCCTTAGTTC
CAGTTTCCCCTT, 193), hMb (s, TTGGTGCTGAACGTCTGGG; as,
CTGTGCCAGGGGCTTAATCTC, 249), hB2M (s, CTGAAAAAGAT
GAGTATGCC; as, ACCCTACATTTTGTGCATAA, 202) and hL32 (s,
TTAAGCGTAACTGGCGGAAAC; as, GAGCGATCTCGGCACAG
TAA, 210).
Cycle threshold (Ct; the ﬁrst cycle in which ampliﬁcation can be
detected) values were obtained from the iCycler iQ software for each
gene of interest (GOI) and control housekeeping genes (HKG; L32
and/or b2m), together with ampliﬁcation efﬁciencies (g; 80–120%).
For the mouse samples, we calculated the relative expression of the
samples to WT controls as reference samples using the gene
expression-relative quantiﬁcation Microsoft Excel add-on macro
(Bio-Rad) that utilizes the following formulas: relative expression ¼
2
 (S DCt-R DCt), where DCt¼GOI Ct HKG Ct. For the human samples,
Ct values were converted to concentration values (ng/ml) by utilizing
the standard curve made by serial dilutions (in duplicates) of a
reference sample. Values were normalized to the corresponding
values of the reference (housekeeping) gene(s) and presented (in
logarithmic scale for visualization purposes) as expression index.
Arthritic score and histopathology. Parafﬁn-embedded joint tissue
samples were sectioned and stained with haematoxylin and eosin.
Arthritic histopathology was assessed (in a blinded fashion) separately
for synovial hyperplasia, existence of inﬂammatory sites, cartilage
destruction, and bone erosion using a semiquantitative (0–5) scoring
as described previously [64].
Transmission electron microscopy. Ankle joints (dissected from
the right hind leg of each mouse—three Tg197 and three WT) were
split open longitudinally through the midline between the tibia and
the talus, and were pre-ﬁxed with 2.5% glutaraldehyde in PBS (pH
7.4) overnight. After post-ﬁxing with 1% osmium tetroxide in PBS for
2 h, the samples were dehydrated in a graded series of ethanol and
processed into Araldite. Semithin sections (1.0 l) were cut and
stained with methylene blue to observe the orientation under the
light microscope. Ultrathin sections (80–90 nm) were then cut with an
ultramicrotome (Riechert-Jung Ultracut E, Leica, Wetzlar, Germany),
mounted on copper grids, counterstained with uranyl acetate and
lead citrate, and evaluated by electron microscope (CM120 Biotwin,
FEI Company, Hillsoro, Oregon, United States).
Supporting Information
Figure S1. Subtractive cDNA Libraries and Large-Scale Sequencing
(A) Outline of experimental strategy for the preparation of
subtracted cDNA libraries and analysis of differential expression.
(B) Summary of normalized and subtracted cDNA libraries and
sequencing results.
Found at DOI: 10.1371/journal.pgen.0010048.sg001 (1.2 MB PDF).
Figure S2. Calculation of the Statistically Signiﬁcant Thresholds of
the R-Statistic at Different Speciﬁcities
(A) Distribution of the R-statistic for the indicated speciﬁcities and
pairwise library comparisons.
(B) Tabulated R-value cutoffs for the indicated speciﬁcities and
pairwise library comparisons.
Found at DOI: 10.1371/journal.pgen.0010048.sg002 (1.4 MB PDF).
Figure S3. Microarray Data Normalization and Analysis Outline
Found at DOI: 10.1371/journal.pgen.0010048.sg003 (775 KB PDF).
Figure S4. Microarray Data Normalization, Evaluation, and Statistical
Selection
(A) Quantile normalization on separated oligonucleotide chip
subunits.
(B) Reproducibility of technical duplicate samples in Affymetrix
hybridizations.
(C) ‘‘Sample type’’-speciﬁc FCMs derived from replicated chips.
Found at DOI: 10.1371/journal.pgen.0010048.sg004 (2.2 MB PDF).
Figure S5. Deregulated Genes Previously Reported to Be Associated
with RA
The associations were identiﬁed through the Biolab Experiment
Assistant text-mining software.
(A) PubMed identiﬁcation numbers of corresponding publications.
(B) Schematic representation of text mining results. Red and green
indicate up-regulated and down-regulated genes, respectively; black
and blue indicate WJ and SF, respectively; numerical values indicate
number of PubMed references.
Found at DOI: 10.1371/journal.pgen.0010048.sg005 (1.5 MB PDF).
Figure S6. Validation of Expression Proﬁling Results
(A–C) SQ RT-PCR of the indicated genes from different cDNA
amounts of arthritic or WT WJs, primary SFs (pSF) and immortalized
SFs (iSF). Ethidium bromide-stained PCR products were quantiﬁed
with GelWorks 1D Advanced (v. 4.01) software and were normalized
against the expression of B2M.
(D) Real-time RT-PCR of the indicated genes from the indicated
samples.
(E) Western blot of whole cell extracts (two independent prepara-
tions) from arthritic and WT immortalized SFs probed with
antibodies to gelsolin and actin. Gelsolin immunostaining was
quantiﬁed with GelWorks 1D Advanced (v. 4.01) software and
normalized against the corresponding actin intensities.
Found at DOI: 10.1371/journal.pgen.0010048.sg006 (2.0 MB PDF).
Table S1. Differential Expression Results from Subtractive Libraries
at 99.99% Speciﬁcity
Found at DOI: 10.1371/journal.pgen.0010048.st001 (32 KB XLS).
Table S2. Differentially Expressed Genes Common in Two Animal
Models of RA from Oligonucleotide DNA Microarray Hybridizations
at 95% Speciﬁcity
Found at DOI: 10.1371/journal.pgen.0010048.st002 (59 KB XLS).
Table S3. GO ‘‘Biological Process’’ Term Frequencies for the
Differentially Expressed Genes in Arthritic SFs and WJs, Selected
from Both Subtractive Libraries and Microarrays
Found at DOI: 10.1371/journal.pgen.0010048.st003 (24 KB XLS).
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